IQVIA is proud to be included in Fortune® “World’s Most Admired Companies™” list 2025 for the eighth consecutive year. We are also excited to earn first place in FORTUNE Health Care: Pharmacy and Other Services category for the fourth time. *
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Maximize your asset’s probability of success in a complex, competitive environment with comprehensive solutions that intelligently connect best-in-class insights, technology, and expertise.
IQVIA Biotech provides full-service clinical development solutions with specialized, dedicated teams.
Explore intelligently designed, flexible solutions that are right for you across clinical development, evidence generation and commercial execution to maximize the value of your asset.
IQVIA’s Market Access Insights provides you with comprehensive, relevant, and actionable content so that you can make informed market access decisions.
Improve the patient experience, enhance data quality and accelerate clinical trials by combining best-in-class eCOA technology with industry-leading expertise.
Pay sites in 30 days, even in difficult locales, and remove the burden of administering clinical trials payments by up to 90%
Petabytes of proprietary data
Non-identified patient records
Countries we operate in, establishing a true global footprint
Faster clinical trial site identification
Technology experts building solutions that meet unique needs in healthcare
Percentage of global pharma sales tracked
.svg){kind=icon}
